Annual Drug Patent Expirations for ZULRESSO
Zulresso is a drug marketed by Sage Therap and is included in one NDA. There are seven patents protecting this drug.
Drug patent litigation for ZULRESSO.
This drug has sixty-four patent family members in twenty-five countries.
The generic ingredient in ZULRESSO is brexanolone. Additional details are available on the brexanolone profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
